Anti-tumor-effects of a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor γ agonist have been also demonstrated in an in vivo mouse model of spontaneous breast cancer [43,118]. This evidence concerns the gene PTGS2 and breast carcinoma.